studi
compar
develop
infect
andor
diseas
beagl
dog
intraderm
infect
leishmania
chagasi
presenc
absenc
lutzomyia
longipalpi
saliva
intraven
infect
anim
spleen
sampl
anim
inocul
parasit
posit
polymeras
chain
reaction
test
leishmania
dna
posit
spleen
cultur
leishmania
detect
earlier
p
frequent
five
five
anim
intraven
infect
anim
intraderm
infect
anim
presenc
two
six
anim
absenc
three
five
anim
salivari
gland
lysat
l
longipalpi
signific
increas
serum
antibodi
leishmania
observ
intraven
infect
group
p
addit
dog
infect
confirm
isol
amastigot
detect
parasit
dna
nevertheless
neg
antileishmania
antibodi
month
infect
anim
intraven
infect
group
develop
progress
decreas
hematocrit
pearson
r
p
hemoglobin
pearson
r
p
infect
period
signific
differ
cours
infect
observ
group
intraderm
infect
anim
paranhossilva
et
al
veterinari
parasitolog
inocul
dog
leishmania
produc
asymptomat
form
infect
also
fail
show
advantag
use
l
longipalpi
saliva
infectionenhanc
agent
experiment
canin
leishmaniasi
zoonot
viscer
leishmaniasi
diseas
caus
leishmania
infantumleishmania
chagasi
affect
dog
human
be
new
world
sever
european
countri
lainson
shaw
enserink
fact
dog
consid
main
domest
reservoir
diseas
dean
dean
dye
vaccin
canin
viscer
leishmaniasi
cvl
would
great
relev
epidemiolog
control
human
diseas
veterinari
medicin
gener
vaccin
would
larg
facilit
exist
adequ
experiment
model
initi
trial
vaccin
candid
could
carri
safe
control
laboratori
condit
current
model
experiment
canin
leishmaniasi
use
larg
number
culturederiv
promastigot
inject
intraven
intraperiton
rout
parasit
promptli
lyse
complement
soar
et
al
releas
rel
larg
amount
antigen
also
differ
immun
respons
rais
antigen
inject
skin
blood
stream
cremer
et
al
author
abranch
et
al
oliveira
et
al
use
amastigot
antigen
distinct
promastigot
natur
infect
form
parasit
mammal
zhang
matlashewski
therefor
although
experi
reproduc
featur
cvl
differ
natur
infect
may
hinder
interpret
result
obtain
experi
design
assess
efficaci
vaccin
candid
natur
dog
infect
promastigot
inject
skin
sand
fli
infect
dog
remain
asymptomat
mani
develop
progress
diseas
lymphoadenopathi
dermat
weigh
loss
anemia
locomot
problem
ideal
model
canin
leishmaniasi
use
vaccin
immunotherapi
studi
would
reproduc
immunolog
aspect
natur
infect
diseas
includ
characterist
immun
respons
gener
antigen
inject
dermi
would
therefor
use
skin
rout
infect
low
number
metacycl
promastigot
warburg
schlein
order
costeffect
model
induc
diseas
short
observ
period
month
would
reason
short
prepat
period
laboratori
work
dog
period
also
observ
natur
infect
moreno
alvar
model
also
induc
diseas
anim
allow
small
group
use
fulfil
ethic
econom
requir
reduc
number
anim
use
experi
experi
perform
use
skin
rout
parasit
inocul
dog
howev
lead
appear
sign
infect
long
period
followup
anim
diseas
never
evid
paranho
et
al
killickkendrick
et
al
titu
ribeiro
propos
lutzomyia
longipalpi
saliva
enhanc
tegumentar
infect
leishmania
major
mice
sinc
observ
confirm
use
differ
strain
mice
speci
leishmania
caus
cutan
lesion
theodo
et
al
lima
titu
l
chagasiinfect
hamster
warburg
et
al
previou
studi
use
lysat
salivari
gland
l
longipalpi
attempt
enhanc
l
chagasi
infect
mongrel
dog
paranho
et
al
clinic
parasitolog
serolog
sign
infect
observ
nine
dog
inocul
intraderm
l
chagasi
except
dog
receiv
leishmania
salin
killickkendrick
et
al
infect
beagl
dog
l
infantum
associ
phlebotomu
perniciosu
salivari
gland
lysat
sgl
studi
howev
investig
possibl
enhanc
effect
sand
fli
saliva
sinc
anim
subject
inject
parasit
without
sgl
author
unabl
observ
macroscop
histolog
differ
site
dermal
infect
l
infantum
presenc
absenc
sgl
parasiteinocul
anim
develop
clinic
sign
diseas
aim
work
improv
experiment
model
cvl
use
futur
test
vaccin
candid
order
possibl
effect
l
longipalpi
sgl
enhanc
intracutan
experiment
l
chagasi
infect
beagl
dog
investig
chose
work
beagl
dog
possibl
high
resist
mongrel
dog
leishmania
infect
use
previou
studi
l
longipalpi
salivari
gland
paranho
et
al
hypothesi
sand
fli
sgl
would
enhanc
infect
dog
l
chagasi
lead
earli
vicer
progress
infect
symptomat
diseas
cours
intraderm
l
chagasi
infect
presenc
absenc
l
longipalpi
saliva
therefor
follow
beagl
dog
refer
infect
group
anim
accord
classic
model
inject
larg
number
parasit
intraven
rout
paranho
et
al
group
experi
intraven
inocul
leishmania
lead
parasit
dissemin
intern
organ
posit
serolog
test
antileishmania
antibodi
l
chagasi
promastigot
strain
isol
spleen
dog
endem
area
bahia
state
brazil
character
reactiv
speciesspecif
monoclon
antibodi
g
grimaldi
oswaldo
cruz
rio
de
janeiro
parasit
grown
vitro
use
modifi
liver
infus
tryptos
lit
medium
contain
mgl
hemin
rpmi
sadsgurski
brodskyn
fetal
calf
serum
parasit
wash
three
time
phosphat
buffer
salin
pb
ph
resuspend
pb
contain
bovin
serum
albumin
bsa
pbsbsa
use
infect
percentag
complementresist
promastigot
present
suspens
determin
accord
techniqu
describ
soar
et
al
leishmania
lysat
use
elisa
obtain
l
chagasi
strain
promastigot
ultrasound
treatment
c
store
c
use
sand
fli
jacobina
bahia
brazil
rear
moniz
research
center
describ
previous
sherlock
sherlock
salivari
gland
isol
nonbloodf
old
femal
sand
fli
five
pair
salivari
gland
place
l
icecold
distil
water
contain
bsa
gland
pool
homogen
made
isoton
addit
concentr
pb
expect
lysat
produc
cutan
hyperemia
inject
intraderm
rabbit
even
amount
correspond
acinu
four
group
old
beagl
dog
see
tabl
subject
follow
infect
protocol
group
six
anim
inocul
promastigot
l
chagasi
stationari
phase
cultur
growth
resuspend
pb
contain
bsa
pbsbsa
l
longipalpi
sgl
twentyf
microlit
parasit
suspens
contain
promastigot
amount
sgl
correspond
acinu
inject
intraderm
intern
face
ear
anim
use
needl
group
b
five
anim
inject
stationaryphas
l
chagasi
promastigot
l
pbsbsa
without
sgl
condit
similar
describ
group
group
c
five
dog
inject
l
pbsbsa
contain
l
longipalpi
sgl
correspond
acinu
condit
similar
describ
group
group
five
anim
inject
intraven
stationaryphas
l
chagasi
resuspend
ml
pb
use
needl
parasit
use
infect
anim
differ
group
growth
batch
number
complementresist
metacycl
promastigot
inject
intraderm
intraven
per
dog
therefor
respect
determin
complementlysi
assay
cite
viabil
parasit
prepar
confirm
observ
motil
promastigot
microscop
aliquot
collect
inject
anim
prior
inclus
studi
anim
vaccin
rabi
coronaviru
infect
treat
antihelminth
anim
also
examin
accord
clinic
laboratori
protocol
describ
test
leishmania
infect
serolog
antileishmania
antibodi
elisa
cultur
spleen
aspir
anim
inject
sand
fli
saliva
also
test
previou
sensit
l
longipalpi
saliva
elisa
see
fig
test
produc
neg
result
sinc
mix
group
male
femal
anim
use
male
anim
subject
vasectomi
order
prevent
fertil
femal
anim
experi
anim
kept
kennel
moniz
research
center
downtown
salvador
nonendem
area
leishmaniasi
period
survey
presenc
vector
leishmania
perform
use
light
trap
neg
result
anim
group
ident
follow
accord
clinic
parasitolog
immunolog
paramet
describ
experi
conduct
accord
oswaldo
cruz
foundat
guidelin
experiment
anim
clinic
examin
anim
carri
fortnightli
veterinarian
accord
previous
establish
protocol
includ
measur
bodi
weight
rectal
temperatur
well
inspect
skin
eye
five
millilit
peripher
blood
collect
monthli
hematolog
test
hematocrit
hemoglobin
quantif
erythrocyt
leukocyt
count
anim
follow
cours
experi
veterinarian
rmcm
provid
necessari
medic
support
anim
preexperi
phase
observ
notic
anim
develop
slight
anemia
therefor
supplement
vitamin
iron
provid
short
period
anim
one
anim
cystiti
two
other
develop
gingiv
one
develop
bacteri
abscess
pad
anim
treat
penicillin
spleen
sampl
collect
month
aspir
anesthesia
cultur
biphas
agarbloodschneid
medium
cultur
examin
weekli
least
month
month
infect
spleen
aspir
also
process
pcr
identif
l
chagasi
dna
lope
wirth
fernand
et
al
briefli
dna
spleen
aspir
prepar
incub
c
hour
l
te
buffer
mm
trishcl
mm
edta
ph
contain
g
ml
proteinas
k
proteas
inactiv
c
min
mixtur
centrifug
c
min
supernat
contain
dna
store
c
use
target
dna
amplif
bp
fragment
constant
region
kdna
minicircl
primer
use
ggg
gag
ggg
cgt
tct
gcg
aa
forward
mixtur
ggc
cca
cta
tat
tac
acc
aac
ccc
ccg
ccc
cta
ttt
tac
acc
aac
ccc
revers
reaction
condit
optim
use
mimic
spleen
sampl
order
obtain
sensit
less
equal
one
parasit
per
reaction
tube
optim
condit
follow
pmol
forward
revers
primer
mixtur
deoxynucleosid
triphosph
concentr
mm
mm
mgcl
u
taq
dna
polymeras
perkinelm
pirogen
rnasefre
h
biotecx
total
volum
l
includ
l
sampl
dna
reaction
cycl
perkinelm
cetu
thermal
cycler
use
follow
condit
c
min
cycl
c
c
c
follow
c
min
one
posit
control
cultur
promastigot
kdna
two
neg
control
h
spleen
sampl
normal
dog
includ
reaction
product
reaction
visual
uv
light
electrophoresi
reaction
solut
agaros
gel
denatur
n
naoh
h
room
temperatur
sampl
l
spot
onto
posit
charg
nylon
membran
hybondn
amersham
use
dot
blot
apparatu
hybri
dot
gibico
fix
uv
exposur
min
plabel
probe
use
hybrid
ipan
v
genebank
access
number
correspond
molecul
clone
minicircl
leishmania
viannia
panamensi
filter
hybrid
c
wash
salinesodiumcitr
solut
contain
sodium
dodecyl
sulfat
left
overnight
xray
film
c
measur
serum
sampl
elisa
paranhossilva
et
al
barral
et
al
briefli
plate
sensit
crude
sonic
antigen
obtain
mixtur
logarithmicand
stationaryphas
l
chagasi
promastigot
l
longipalpi
salivari
gland
plate
wash
block
pb
contain
skim
milk
serum
anim
appli
duplic
dilut
detect
antileishmania
antibodi
detect
antisalivari
gland
antibodi
follow
antidog
iggperoxidas
conjug
sigma
chemic
st
loui
usa
enzymat
reaction
develop
measur
describ
elsewher
paranhossilva
et
al
measur
perform
least
twice
order
allow
accur
comparison
among
group
among
blood
sampl
collect
differ
period
test
perform
sampl
random
differ
plate
result
express
mean
standard
error
mean
sem
od
nm
obtain
test
sera
differ
anim
group
peripher
blood
leukocyt
separ
gradient
ficolhypaqu
histopaqu
usa
viabl
mononuclear
cell
adjust
ml
rpmi
medium
gibco
supplement
normal
canin
serum
gml
gentamycin
mm
acid
hepe
sigma
mm
lglutamin
cell
per
well
distribut
flatbottom
microtitr
plate
volum
l
equal
volum
medium
alon
contain
g
concanavin
cona
ad
treatment
done
triplic
cultur
incub
day
c
humidifi
atmospher
co
optim
concentr
cona
time
stimul
use
studi
establish
preliminari
experi
cell
prolifer
quantifi
measur
incorpor
h
thymidin
amersham
twelv
hour
harvest
ci
ad
per
well
cell
harvest
fiber
filter
util
cell
harvest
skatron
radioact
uptak
determin
liquid
scintil
beta
counter
intens
prolif
respons
express
stimul
index
calcul
divid
mean
count
obtain
cona
contain
well
mean
count
control
well
stimul
indic
equal
higher
consid
indic
prolifer
threshold
posit
lymphoprolif
respons
base
data
previou
experi
perform
laboratori
use
anim
studi
mean
valu
prolif
respons
cell
presenc
medium
alon
plu
three
standard
deviat
mean
encompass
valu
correspond
stimul
index
lower
dossanto
et
al
unpublish
data
shown
graph
numer
dot
repres
individu
anim
line
repres
mean
sem
result
obtain
group
order
correct
natur
heterogen
bodi
weight
studi
group
variabl
express
rel
percentu
bodi
weight
gain
rel
observ
begin
experi
lymphoprolif
respons
express
stimul
index
ratio
mean
cpm
obtain
cell
incub
mitogen
nonstimul
cell
signific
differ
observ
among
group
test
use
oneway
analysi
varianc
anova
ftest
found
signific
differ
two
group
identifi
use
studentnewman
kleu
test
trend
measur
use
person
correl
coeffici
r
follow
comparison
slope
intercept
two
line
appropri
crosstabl
comparison
fisher
exact
probabl
test
use
critic
level
signific
admit
glantz
group
inject
intraderm
l
chagasi
associ
l
longipalpi
sgl
two
six
anim
parasit
cultur
spleen
parasit
identifi
cultur
month
infect
pcr
posit
leishmania
dna
five
examin
anim
anim
howev
pcr
vari
neg
posit
differ
sampl
chang
observ
intens
antileishmania
antibodi
activ
sera
fig
signific
lymphoprolif
respons
upon
stimul
cona
observ
three
four
examin
anim
si
one
anim
si
clinicallaboratori
featur
studi
chang
significantli
group
experi
two
anim
die
experi
anim
die
subtli
eighth
month
infect
topic
treatment
triatox
amitraz
sarcopt
scabei
infest
anim
die
month
infect
asthenia
develop
suddenli
white
blood
cell
count
reveal
leukocyt
neutrophil
two
anim
anim
leishmania
amastigot
detect
spleen
see
tabl
three
five
anim
group
inject
intraderm
l
chagasi
alon
spleen
cultur
posit
leishmania
parasit
isol
cultur
two
anim
one
anim
month
infect
pcr
posit
leishmania
dna
spleen
sampl
four
examin
anim
anim
howev
pcr
vari
neg
posit
differ
sampl
circul
antileishmania
antibodi
level
remain
low
experi
small
increas
level
observ
month
infect
fig
posit
lymphoprolif
respons
cona
observ
three
four
examin
anim
si
one
anim
si
clinicallaboratori
featur
significantli
chang
group
experi
one
anim
sacrif
month
infect
develop
gingiv
abscess
loss
one
tooth
spleen
cultur
perform
experi
neg
leishmania
anim
cultur
pcr
elisa
detect
antileishmania
antibodi
serum
consist
neg
group
uninfect
anim
experi
lymphoprolif
respons
cona
significantli
higher
cell
treat
medium
alon
three
four
examin
anim
si
one
anim
si
investig
clinicallaboratori
paramet
show
signific
chang
experi
anim
group
inocul
l
chagasi
intraven
rout
posit
spleen
cultur
parasit
detect
spleen
first
month
parasit
inocul
one
anim
second
month
other
spleen
cultur
remain
posit
throughout
month
observ
tabl
intraven
infect
anim
examin
month
infect
posit
pcr
leishmania
dna
investig
time
point
anim
infect
intraven
rout
signific
increas
level
antileishmania
antibodi
serum
month
infect
fig
level
antileishmania
antibodi
reach
plateau
seventh
month
infect
remain
high
end
experi
posit
lymphoprolif
respons
cona
observ
three
examin
anim
si
anim
group
level
hematocrit
hemoglobin
decreas
experi
averag
level
hematocrit
vari
begin
end
experi
pearson
r
p
averag
level
hemoglobin
vari
begin
end
experi
pearson
r
p
investig
clinicallaboratori
paramet
show
signific
chang
experi
one
anim
die
suddenli
ninth
month
infect
although
immedi
event
caus
death
anim
identifi
anim
papular
dermat
anemia
low
leukocyt
count
day
death
also
posit
spleen
cultur
leishmania
differ
rate
posit
spleen
cultur
intraven
intraderm
infect
group
statist
signific
second
eighth
month
infect
p
fisher
exact
probabl
test
longer
signific
ninth
month
infect
p
fisher
exact
probabl
test
differ
incid
posit
spleen
cultur
leishmania
group
intraderm
infect
anim
group
b
p
fisher
test
differ
incid
posit
pcr
among
group
infect
leishmania
p
fisher
exact
probabl
test
comparison
intraderm
infect
anim
group
b
anim
infect
intraven
rout
signific
increas
serum
level
antileishmania
antibodi
p
anova
follow
studentnewman
kleu
test
statist
signific
differ
serum
antileishmania
antibodi
observ
group
anim
intraderm
infect
l
chagasi
group
without
group
b
sand
fli
saliva
intraderm
infect
group
b
control
noninfect
group
antibodi
l
longipalpi
salivari
gland
detect
anim
test
infect
fig
among
clinicallaboratori
paramet
hematocrit
hemoglobin
significantli
decreas
intraven
infect
group
compar
control
group
decreas
level
hematocrit
hemoglobin
statist
signific
test
comparison
slop
two
line
hematocrit
p
hemoglobin
p
bodi
weight
loss
appear
higher
intraven
infect
anim
although
differ
statist
signific
p
shown
paper
intraven
intraderm
inject
l
chagasi
promastigot
effect
term
infect
beagl
dog
infect
intraderm
rout
howev
develop
slowli
anim
remain
asymptomat
long
period
inde
clinic
laboratori
paramet
tend
progress
less
favor
intraven
intraderm
infect
anim
even
complet
medic
support
provid
exclud
use
antileishmania
drug
anim
former
group
develop
anemia
persist
high
serum
level
antileishmania
antibodi
spleen
parasit
infect
sign
less
promin
intraderm
infect
anim
sinc
parasit
detect
sporad
spleen
parasit
cultiv
pcr
pcr
spleen
cultur
alway
posit
intraven
infect
anim
observ
sporad
intraderm
infect
anim
mathi
deplaz
found
similar
sensit
lymph
node
cultur
pcr
experi
howev
pcr
capabl
detect
leishmania
dna
even
sampl
neg
parasit
cultur
even
intraderm
infect
anim
neg
pcr
result
test
one
possibl
reason
variabl
detect
leishmania
spleen
aspir
intraderm
infect
anim
pcr
cultur
could
noncontinu
multifoc
distribut
parasit
tissu
usual
present
anim
low
parasit
burden
although
control
dna
integr
amplif
constitut
canin
gene
perform
small
sampl
obtain
spleen
punctur
fact
materi
anim
group
handl
strictli
condit
make
unlik
intergroup
differ
pcr
result
poor
dna
preserv
differ
infect
effici
intraven
intraderm
rout
observ
work
may
complet
ascrib
larger
amount
parasit
inject
intraven
sinc
infect
diseas
induc
similar
effici
intraven
promastigot
dose
vari
abranch
et
al
paranho
et
al
nieto
et
al
hand
intraderm
inject
promastigot
produc
mild
sign
diseas
one
five
infect
anim
recent
studi
santosgom
et
al
toler
induc
intraven
releas
antigen
cremer
et
al
provid
happen
intraven
model
cvl
could
theoret
increas
infect
leishmania
inject
rout
toler
induc
leishmania
antigen
would
howev
limit
use
intraven
model
infect
particularli
experi
design
assess
efficaci
vaccin
candid
possibl
tolerogen
condit
efficaci
vaccin
candid
could
underestim
intraderm
model
infect
kill
live
parasit
promptli
phagocyt
macrophag
langerhan
cell
presum
tolerogen
effect
would
less
like
occur
schwartz
work
confirm
previou
observ
group
paranho
et
al
killickkendrick
et
al
santosgom
et
al
evid
infect
take
long
period
develop
anim
infect
dermal
inject
leishmania
sign
diseas
may
never
present
anim
clinic
cours
experiment
cvl
may
influenc
number
factor
includ
strain
virul
parasit
dose
sourc
development
stage
promastigot
dog
breed
solanogallego
et
al
less
easili
control
event
review
moreno
alvar
unpredict
natur
experiment
infect
may
also
reflect
spectrum
clinic
respons
seen
natur
infect
hommel
et
al
fact
littl
known
dynam
natur
leishmania
infect
dog
low
number
parasit
inject
intraderm
one
probabl
repeat
inocul
nutrit
statu
concomit
diseas
may
affect
cours
infect
differ
anim
variabl
condit
prepat
period
day
appear
posit
serolog
leishmania
estim
quinnel
et
al
natur
infect
anim
may
never
seroconvert
even
month
infect
hommel
et
al
half
serolog
posit
anim
may
develop
clinic
sign
diseas
hommel
et
al
henc
singl
exposur
parasit
select
experiment
model
healthi
dog
may
abl
mount
effect
cellular
immun
respons
may
addit
reduc
success
intraderm
model
cvl
work
tri
improv
experiment
model
cvl
associ
salivari
gland
l
longipalpi
natur
vector
l
chagasi
low
number
infect
parasit
inocul
dermi
addit
l
longipalpi
sgl
infect
inoculum
chang
cours
l
chagasi
infect
lead
earli
amastigot
detect
spleen
increas
parasit
burden
organ
therefor
advantag
term
produc
experiment
model
cvl
order
exclud
possibl
put
previou
contact
sand
fli
might
immun
anim
salivari
gland
compon
thu
interf
possibl
infectionenhanc
effect
saliva
belkaid
et
al
anim
sera
test
infect
presenc
antil
longipalpi
salivari
gland
antibodi
lack
enhanc
effect
sgl
explain
antisaliva
antibodi
activ
sinc
anim
neg
activ
cutan
inject
sgl
effect
result
agreement
observ
l
longipalpi
sgl
high
vasodil
activ
enhanc
experiment
l
chagasi
infect
mongrel
dog
paranho
et
al
may
vari
abil
enhanc
infect
murin
model
tegumentar
leishmaniasi
castrosousa
et
al
warburg
et
al
kinet
appear
antileishmania
antibodi
sera
intraven
intraderm
infect
anim
disclos
import
characterist
humor
immun
respons
leishmania
dog
spite
infect
confirm
anim
infect
intraven
intraderm
rout
intraven
infect
rel
high
titer
antileishmania
antibodi
even
group
increas
antibodi
level
occur
fifth
month
infect
least
month
parasit
detect
spleen
find
consist
observ
natur
infect
anim
serolog
survey
canin
leishmaniasi
endem
area
anim
parasit
spleen
low
undetect
antileishmania
antibodi
elisa
ashford
et
al
popul
infect
dog
neg
serolog
may
constitut
anim
asymptomat
infect
control
therefor
low
parasit
burden
describ
herein
anim
infect
intraderm
undergo
diseas
progress
high
parasit
burden
still
low
antibodi
respons
last
cours
infect
could
suggest
defici
respons
wherea
commonli
observ
situat
name
high
intens
tissu
parasit
diseas
progress
high
level
specif
antibodi
would
occur
anim
immun
respons
leishmania
evolv
cabral
et
al
final
suppress
lymphoprolif
respons
nonspecif
mitogen
report
symptomat
appar
healthi
l
infantuminfect
anim
de
luna
et
al
moreno
et
al
rhalem
et
al
even
earli
stage
infect
de
luna
et
al
observ
confirm
studi
peripher
mononuclear
cell
even
anim
intraven
infect
l
chagasi
rel
persist
parasit
burden
posit
elisa
prolifer
well
cell
control
uninfect
dog
presenc
cona
data
agre
previous
report
observ
pinelli
et
al
nonspecif
immunosuppress
necessarili
occur
l
chagasil
infantuminfect
dog
possibl
develop
nonspecif
immunosuppress
cvl
could
depend
yet
unidentifi
parasiteandor
hostderiv
factor
howev
exclud
support
ministri
scienc
technolog
brazil
brazilian
nation
research
council
cnpq
grant
pronex
experi
conduct
accord
current
brazilian
law
oswaldo
cruz
foundat
guidelin
biosafeti
experiment
anim
